03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
As sophisticated employers know, an employer must track and comply with developments not only in fed...
Read More >
We are delighted to announce the launch of the second edition of our Private Equity Trends Monitor, ...
Read More >
With 169 special purpose acquisition company (SPAC) initial public offerings (IPOs) and 102 SPAC mer...
Read More >
The Minnesota Legislature recently passed, and Governor Walz signed, the Jobs and Economic Developme...
Read More >
James Doty, former Commissioner of the Public Company Accounting Oversight Board (PCAOB) was once as...
Read More >
Q: Are there any new cases involving Pennsylvania’s Medical Marijuana Act in the context of employm...
Read More >